|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Magee CJ, Ghaneh P and Neoptolemos JP:
Surgical and medical therapy for pancreatic carcinoma. Best Pract
Res Clin Gastroenterol. 16:435–455. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yeo TP, Hruban RH, Leach SD, et al:
Pancreatic cancer. Curr Probl Cancer. 26:176–275. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warshaw AL and Fernández-del Castillo C:
Pancreatic carcinoma. N Engl J Med. 326:455–465. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koorstra JB, Hustinx SR, Offerhaus GJ and
Maitra A: Pancreatic carcinogenesis. Pancreatology. 8:110–125.
2008. View Article : Google Scholar
|
|
6
|
Mueller MT, Hermann PC, Witthauer J,
Rubio-Viqueira B, Leicht SF and Huber S: Combined targeted
treatment to eliminate tumorigenic cancer stem cells in human
pancreatic cancer. Gastroenterology. 137:1102–1113. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanaka H, Nakamura M, Kameda C, Kubo M,
Sato N and Kuroki S: The Hedgehog signaling pathway plays an
essential role in maintaining the
CD44+CD24−/low subpopulation and the side
population of breast cancer cells. Anticancer Res. 29:2147–2157.
2009.PubMed/NCBI
|
|
8
|
Shankar S, Nall D, Tang SN, Meeker D,
Passarini J, Sharma J and Srivastava RK: Resveratrol inhibits
pancreatic cancer stem cell characteristics in human and KrasG12D
transgenic mice by inhibiting pluripotency maintaining factors and
epithelial-mesenchymal transition. PLoS One. 6:e165302011.
View Article : Google Scholar
|
|
9
|
Srivastava RK, Tang SN, Zhu W, Meeker D
and Shankar S: Sulforaphane synergizes with quercetin to inhibit
self-renewal capacity of pancreatic cancer stem cells. Front
Biosci. 3:515–528. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Beachy PA, Karhadkar SS and Berman DM:
Tissue repair and stem cell renewal in carcinogenesis. Nature.
432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruiz i Altaba A, Mas C and Stecca B: The
Gli code: an information nexus regulating cell fate, stemness and
cancer. Trends Cell Biol. 17:438–447. 2007.PubMed/NCBI
|
|
12
|
Ruiz i Altaba A: Therapeutic inhibition of
Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell
targets? Cancer Cell. 14:281–283. 2008.PubMed/NCBI
|
|
13
|
Bailey JM, Singh PK and Hollingsworth MA:
Cancer metastasis facilitated by developmental pathways: Sonic
hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem.
102:829–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Y, Tian X, Xie X, Zhuang Y, Wu W and
Wang W: Expression and regulation of hedgehog signaling pathway in
pancreatic cancer. Langenbecks Arch Surg. 395:515–525. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Olive KP, Jacobetz MA, Davidson CJ, et al:
Inhibition of Hedgehog signaling enhances delivery of chemotherapy
in a mouse model of pancreatic cancer. Science. 324:1457–1461.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee CJ, Dosch J and Simeone DM: Pancreatic
cancer stem cells. J Clin Oncol. 26:2806–2812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang SN, Fu J, Nall D, Rodova M, Shankar S
and Srivastava RK: Inhibition of sonic hedgehog pathway and
pluripotency maintaining factors regulate human pancreatic cancer
stem cell characteristics. Int J Cancer. 131:30–40. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao J, An Y, Wie JS, et al: Cyclopamine
reverts acquired chemoresistance and down-regulates cancer stem
cell markers in pancreatic cancer cell lines. Swiss Med Wkly.
141:w132082011.PubMed/NCBI
|
|
19
|
Strand MF, Wilson SR, Dembinski JL, et al:
A novel synthetic smoothened antagonist transiently inhibits
pancreatic adenocarcinoma xenografts in a mouse model. PLoS One.
6:e199042011. View Article : Google Scholar
|
|
20
|
Nüsslein-Volhard C and Wieschaus E:
Mutations affecting segment number and polarity in
Drosophila. Nature. 287:795–801. 1980.PubMed/NCBI
|
|
21
|
Hooper JE and Scott MP: Communicating with
Hedgehogs. Nat Rev Mol Cell Biol. 6:306–317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kalderon D: Transducing the hedgehog
signal. Cell. 103:371–374. 2000. View Article : Google Scholar
|
|
23
|
Kayed H, Kleeff J, Osman T, Keleg S,
Büchler MW and Friess H: Hedgehog signaling in the normal and
diseased pancreas. Pancreas. 32:119–129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Berman DM, Karhadkar SS, Maitra A, et al:
Widespread requirement for Hedgehog ligand stimulation in growth of
digestive tract tumors. Nature. 425:846–851. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kayed H, Kleeff J, Keleg S, et al: Indian
hedgehog signaling pathway: expression and regulation in pancreatic
cancer. Int J Cancer. 110:668–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thayer SP, di Magliano MP, Heiser PW, et
al: Hedgehog is an early and late mediator of pancreatic cancer
tumorigenesis. Nature. 425:851–856. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao J, Li Z, Chen Z, et al: Antisense Smo
under the control of the PTCH1 promoter delivered by an adenoviral
vector inhibits the growth of human pancreatic cancer. Gene Ther.
13:1587–1594. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu XF, Guo CY, Liu J, et al: Gli1
maintains cell survival by up-regulating IGFBP6 and Bcl-2 through
promoter regions in parallel manner in pancreatic cancer cells. J
Carcinog. 8:132009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoo YA, Kang MH, Lee HJ, et al: Sonic
hedgehog pathway promotes metastasis and lymphangiogenesis via
activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer
Res. 71:7061–7070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Buonamici S, Williams J, Morrissey M, et
al: Interfering with resistance to smoothened antagonists by
inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med.
2:51ra702010.PubMed/NCBI
|
|
31
|
Chen X, Lingala S, Khoobyari S, Nolta J,
Zern MA and Wu J: Epithelial mesenchymal transition and hedgehog
signaling activation are associated with chemoresistance and
invasion of hepatoma subpopulations. J Hepatol. 55:838–845. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
33
|
Di Fiore R, Santulli A, Ferrante RD, et
al: Identification and expansion of human osteosarcoma-cancer-stem
cells by long-term 3-aminobenzamide treatment. J Cell Physiol.
219:301–313. 2009.PubMed/NCBI
|
|
34
|
Tirino V, Desiderio V, d’Aquino R, et al:
Detection and characterization of CD133+ cancer stem
cells in human solid tumours. PLoS One. 3:e34692008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mahller YY, Williams JP, Baird WH, et al:
Neuroblastoma cell lines contain pluripotent tumor initiating cells
that are susceptible to a targeted oncolytic virus. PLoS One.
4:e42352009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pode-Shakked N, Metsuyanim S, Rom-Gross E,
et al: Developmental tumourigenesis: NCAM as a putative marker for
the malignant renal stem/progenitor cell population. J Cell Mol
Med. 13:1792–1808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Walter D, Satheesha S, Albrecht P, et al:
CD133 positive embryonal rhabdomyosarcoma stem-like cell population
is enriched in rhabdospheres. PLoS One. 6:e195062011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han YG, Spassky N, Romaguera-Ros M,
Garcia-Verdugo JM, Aguilar A, Schneider-Maunoury S and
Alvarez-Buylla A: Hedgehog signaling and primary cilia are required
for the formation of adult neural stem cells. Nat Neurosci.
11:277–284. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singh BN, Fu J, Srivastava RK and Shankar
S: Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits
pancreatic cancer stem cell characteristics: molecular mechanisms.
PLoS One. 6:e273062011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW and Guba M: Distinct populations of cancer stem cells
determine tumor growth and metastatic activity in human pancreatic
cancer. Cell Stem Cell. 1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dembinski JL and Krauss S:
Characterization and functional analysis of a slow cycling stem
cell-like subpopulation in pancreas adenocarcinoma. Clin Exp
Metastasis. 26:611–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Feldmann G, Dhara S, Fendrich V, et al:
Blockade of hedgehog signaling inhibits pancreatic cancer invasion
and metastases: a new paradigm for combination therapy in solid
cancers. Cancer Res. 67:2187–2196. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Maitah MY, Ali S, Ahmad A, Gadgeel S and
Sarkar FH: Up-regulation of sonic hedgehog contributes to
TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells.
PLoS One. 6:e160682011.PubMed/NCBI
|
|
44
|
Liao X, Siu MK, Au CW, et al: Aberrant
activation of hedgehog signaling pathway in ovarian cancers: effect
on prognosis, cell invasion and differentiation. Carcinogenesis.
30:131–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Olmeda D, Jordá M, Peinado H, Fabra A and
Cano A: Snail silencing effectively suppresses tumour growth and
invasiveness. Oncogene. 26:1862–1874. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
